Literature DB >> 2600604

Secretion of tumor necrosis factor during fetal and neonatal development of the mouse: ontogenic inflammation.

K Yamasu1, H Onoe, G Soma, H Oshima, D Mizuno.   

Abstract

Inflammation plays an important role in homeostasis of the body. We therefore can assume that an inflammatory state occurs during ontogenesis of animals. To address this problem, we examined the ability of tumor necrosis factor (TNF), one of the inflammatory mediators, to be secreted by mouse cells during development. We cultured cells prepared from various parts of fetuses (10-19 days of gestation) and postnatal brains by collagenase digestion and assayed the secreted TNF activity by the L-929 cytotoxicity test. We found TNF activity by fetal cells without any stimulation. The spontaneous secretion of TNF was relatively high at around 13-15 days of gestation. The secretion was enhanced by lipopolysaccharide (LPS), showing that fetal cells are in an activated state for TNF secretion. These TNF activities were neutralized completely by rabbit anti-murine TNF antibody. Spontaneous and LPS-enhanced secretion by postnatal brain cells reached a peak around 7 days after birth, and thereafter declined rapidly. This time course was well correlated to the increase in the weight of brain. The producing cells were negative in macrophage marker surface antigen, and heterogeneous in relation to adherence and phagocytic activity, showing that TNF is secreted by various types of cells in the fetal body. These results suggest the presence of an inflammation-like state during ontogenesis. We consider that this "ontogenic inflammation" may be the prototype of inflammation, which can regulate homeostasis of the adult body.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2600604

Source DB:  PubMed          Journal:  J Biol Response Mod        ISSN: 0732-6580


  8 in total

1.  Injury-induced neurogenesis: consideration of resident microglia as supportive of neural progenitor cells.

Authors:  Christopher A McPherson; Andrew D Kraft; G Jean Harry
Journal:  Neurotox Res       Date:  2010-06-04       Impact factor: 3.911

Review 2.  Tumor necrosis factor and immunopathology.

Authors:  P F Piguet; G E Grau; P Vassalli
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages.

Authors:  Kazue Nakata; Hiroyuki Inagawa; Takashi Nishizawa; Teruko Honda; Chie Kohchi; Yasuhito Tonomoto; Hiroshi Yoshimura; Naofumi Nagasue; Shynji Natori; Hiroshi Terada; Gen-Ichiro Soma
Journal:  Int J Colorectal Dis       Date:  2005-08-10       Impact factor: 2.571

Review 4.  Potential roles for tumour necrosis factor alpha during embryonic development.

Authors:  M A Wride; E J Sanders
Journal:  Anat Embryol (Berl)       Date:  1995-01

5.  Long-term disorders of behavior in rats induced by administration of tumor necrosis factor during early postnatal ontogenesis.

Authors:  O E Zubareva; V M Klimenko
Journal:  Neurosci Behav Physiol       Date:  2008-12-17

Review 6.  Human immunodeficiency virus type 1 infection of the brain.

Authors:  W J Atwood; J R Berger; R Kaderman; C S Tornatore; E O Major
Journal:  Clin Microbiol Rev       Date:  1993-10       Impact factor: 26.132

Review 7.  Cytokines and myelination in the central nervous system.

Authors:  Thomas Schmitz; Li-Jin Chew
Journal:  ScientificWorldJournal       Date:  2008-11-02

Review 8.  The role of tumor necrosis factor receptor superfamily members in mammalian brain development, function and homeostasis.

Authors:  Jason P Twohig; Simone M Cuff; Audrey A Yong; Eddie C Y Wang
Journal:  Rev Neurosci       Date:  2011-08-24       Impact factor: 4.353

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.